Enhanced Comprehensive HIV Prevention Planning and Implementation for Metropolitan Statistical Areas Most Affected by HIV/AIDS: Phase II

Post Date

March 25th 2011

Application Due Date

May 25th 2011

Funding Opportunity Number

CDC-RFA-PS11-1117

CFDA Number(s)

93.523

Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Health

Number of Awards

12

Eligibility Categories

Other

Applicants eligible to apply for this cooperative agreement are limited to twelve (12) entities in specific Metropolitan Statistical Areas (MSAs) or specified Metropolitan Divisions (MDs) that have the highest estimated AIDS prevalence at the end of 2007. These twelve eligible areas received funding for Phase I of the project under announcement CDC-RFA-PS10-10181. The entities eligible to apply for funds under this FOA are as follows: 1. New York City Department of Health and Mental Hygiene 2. Los Angeles County Public Health Department 3. District of Columbia Department of Health 4. Chicago Department of Public Health 5. Georgia Department of Human Resources 6. Florida State Department of Health 7. City of Philadelphia Public Health Department 8. Houston Department of Health and Human Services 9. San Francisco Department of Public Health 10. Maryland State Department of Health 11. Texas State Department of Health Services 12. Puerto Rico Department of Health

Funding

• Estimated Total Funding:

  $64000000

• Award Range:

  $400000 - $600000

Grant Description

This announcement supports integration of diagnostic and prevention services for the Human Immunodeficiency Virus (HIV), hepatitis C virus (HCV), hepatitis B virus (HBV), sexually transmitted diseases (STD); and tuberculosis (TB) because of CDC's greater understanding of the extent to which: ╔ STDs increase the risk for HIV infection. ╔ Control of TB, viral hepatitis, and STDs is needed to protect the health of HIV-infected persons. ╔ HIV, viral hepatitis and STDs share common risks and modes of transmission. ╔ Risks for acquiring theses diseases are associated with similar behaviors and environmental conditions and have reciprocal or interdependent effects. ╔ Clinical course and outcomes of these diseases are influenced by co-infection (for example, HIV/TB can be deadly, and TB accelerates HIV disease progression). ╔ Populations disproportionately affected by HIV are also disproportionately affected by infections with TB, HCV, HBV, and STDs.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  Centers for Disease Control and Prevention

• Agency Contact:

  CDC
  Procurement and Grants Office (PGO)
  Technical Information Management Section (TIMS)
  Phone 770-488-2700

• Agency Mailing Address:

  Technical Information Management Section (TIMS)

• Agency Email Address:

  pgotim@cdc.gov

• More Information:

  This is not an active link. Please click on the words "Full Announcement" at the top of this page.